Pathways of diabetes distress, decisional balance, self‐efficacy and resilience to quality of life in insulin‐treated patients with type 2 diabetes: A 9‐month prospective study

Author(s):  
Hui‐Chun Hsu ◽  
Shi‐Yu Chen ◽  
Yau‐Jiunn Lee ◽  
Wan‐Yi Chen ◽  
Ruey‐Hsia Wang
2019 ◽  
Vol 2 (1) ◽  
pp. 15-17
Author(s):  
Anna Kohut ◽  
O. Potapov ◽  
I. Frankova ◽  
M. Bobryk ◽  
J. Komisarenko ◽  
...  

Background: Diabetes Mellitus type 2 (T2DM) has been becoming a globalworld health problem affecting countries with different income level (Mogre,Johnson, Tzelepis, Shaw, & Paul, 2017). The low level of compliance and theincreased level of the diabetes distress has been closely associated with destituteglycemic control. Some diabetes-specific psychological variables may beimportant for psychological status of patients and glycemic control to theachievement of individual glycemic targets (Indelicato et al., 2017). Therefore,alexithymia – psychological clinical characteristic of the reduced emotionalcomponent that could have been associated with the metabolic syndrome inpatients with type 2 diabetes, for example (Lemche, Chaban, & Lemche, 2014). Itis important to consider the clinical evaluation of mental aspects in patients withT2DM, however, in order to preventing potentially unfavorable self-care behaviorleading to complications of this disease, including a decrease in the quality of lifelevel (Conti et al., 2017). Patient's level of the quality of life is the one of mainimportant components of treatment adherence and clinical decision making forimproving the effectiveness of therapy (Chaban, Khaustova, & Bezsheiko, n.d.).The low level of medication compliance and quality of life could have beenaddicted in consequence to non-adherence and respectively – inefficiency oftherapy of these patients. Therefore, multidisciplinary connection – involvingmental health care specialists can potentially improve treatment effectiveness(Kogut at al., 2018).


Author(s):  
Norbert Hermanns ◽  
Marijke A. Bremmer ◽  
Frank J. Snoek

Diabetes distress is a common emotional response in people with diabetes. It is associated with depression and has a negative impact on quality of life and diabetes control. This chapter reviews current concepts of diabetes-specific distress. Diabetes-related distress is defined as an emotional response to stressors, fears, and worries associated with the burden of living with and managing the chronic disease diabetes mellitus. Evidence to date on point prevalence, persistence of diabetes distress, and incidence in people with type 1 and type 2 diabetes are reviewed as well as the associations between diabetes distress and depression. Conceptual and clinical implications for the assessment and management of diabetes distress are discussed.


2013 ◽  
Vol 37 (3) ◽  
pp. 501-510 ◽  
Author(s):  
Matthew M. Carper ◽  
Lara Traeger ◽  
Jeffrey S. Gonzalez ◽  
Deborah J. Wexler ◽  
Christina Psaros ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Mohammed A. Batais ◽  
Abdulaziz F. Alfraiji ◽  
Abdulrahman Abdullah Alyahya ◽  
Ouf Abdullatif Aloofi ◽  
Mohammad Khalid Almashouq ◽  
...  

In recent years, the global burden of diabetes distress has increased significantly worldwide, imposing mental health issues on patients and the healthcare system. Hence, this study aimed to estimate the prevalence of diabetes distress and determine its psychosocial predictors among Saudi adults with type 2 diabetes mellitus (T2DM). This cross-sectional, observational study was conducted at Diabetes Clinics, Tertiary Care Academic Medical Center, King Saud University Medical City, Riyadh, Saudi Arabia. The survey questionnaire was distributed to 423 participants. The sample size was 384, where the prevalence of diabetes distress was 48.5%. Based on 5% precision and a confidence interval of 95%, the response rate was 78.25% (334 respondents), among which 61.4% of respondents were females, the remaining 38.6% were males, and the mean age was 56.39 years. The mean scores for the Saudi Arabian Diabetes Distress Scale-17 (SADDS-17) subdomains including emotional burden, physician-related distress, regimen-related distress, and interpersonal distress were 2.63 ± 1.29, 2.31 ± 1.44, 2.48 ± 1.16, and 2.23 ± 1.24, respectively. Based on the World Health Organization Quality of Life Assessment Instrument, Short Version (WHOQOL-BREF) transformed scores, the quality of life was recorded as 62.7%. There was a statistically significant positive correlation between the Hospital Anxiety and Depression Scale (HADS) score (r = 0.287, p < 0.01) and the total SADDS-17 scores. The Patient Health Questionaire (PHQ) 15 scores showed significant positive correlations with the total SADDS-17 scores (r = 0.288, p < 0.01) and each of the four subdomains. Our present study revealed that diabetes distress prevalence is alarmingly high among patients in Saudi Arabia, Riyadh. Our findings provide evidence that physical symptoms, quality of life, depression, and anxiety are the notable predictors of diabetes distress.


Medwave ◽  
2021 ◽  
Vol 21 (02) ◽  
pp. e8132-e8132
Author(s):  
Irma Elizabeth Huayanay-Espinoza ◽  
Felix Guerra-Castañon ◽  
Michael Reyes-Diaz ◽  
María Lazo-Porras ◽  
Celso de la Cruz-Luque ◽  
...  

Quality of life and self-efficacy assessments are increasingly applied in research with type 2 diabetes mellitus patients due to the impact of the disease on their lives. This study aimed to describe the quality of life and self-efficacy in type 2 diabetes mellitus patients and describe the association of quality of life and self-efficacy with demographic, metabolic, and clinical variables. This is a secondary data analysis from a cross-sectional study: “Metabolic control in patients with type 2 diabetes mellitus in a public hospital in Peru: a cross-sectional study in a low-middle income country”. Data were obtained by standardized interviews and evaluation of medical records. The evaluation tools used were the Diabetes 39 questionnaire (D-39) to measure the quality of life and the General Self-Efficacy scale (GSE) for self-efficacy. The median scores of the D-39 and GSE were 34.6 and 34, respectively. The D-39 dimension with the highest score was “anxiety and concern.” Better quality of life was associated with being older than 65 years old, not having complications, and the absence of depression. No significant association was found between self-efficacy and the quality of life score. Results suggest patients with type 2 diabetes mellitus have a poor quality of life. Patient-centered strategies for type 2 diabetes mellitus care must consider these psychosocial factors to improve disease control and quality of life.


Sign in / Sign up

Export Citation Format

Share Document